Processa pharmaceuticals secures strategic investment and evaluates corporate crypto treasury strategies

Vero beach, fla., aug. 07, 2025 (globe newswire) -- processa pharmaceuticals, inc. (nasdaq: pcsa), a clinical-stage biopharmaceutical company developing next generation cancer (ngc) therapies for cancer patients, today announced that it has secured a strategic investment and that it is evaluating corporate cryptocurrency treasury strategies as part of its broader financial and growth objectives.
PCSA Ratings Summary
PCSA Quant Ranking